Tag Archives: FIZZ

Top 10 Safest Stocks For 2019

In a junior sector that has become quite a stock-picker’s market over the past nine months, I find some of the safest and lowest risk opportunities come when a company is undergoing a major change. Atlantic Gold (OTCPK:SPVEF) was one such idea I highlighted last year, as the company was set to transform itself into Canada’s newest junior gold producer. The stock has since moved from US$0.60 to US$1.40 and the re-rating I expect has nearly come to fruition. A company with a similar profile that I’ve had my eye on was Harte Gold (OTCPK:HRTFF), but the stock got well ahead of itself earlier this year and I exited my position. Since that time the stock has spent the last six months consolidating and finally looks it may be ready to resume the new uptrend it began earlier this year.

Top 10 Safest Stocks For 2019: Vanguard Mega Cap Growth ETF (MGK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fernwood Investment Management LLC lessened its stake in VANGUARD MEGA CAP 300 GROWTH ETF (BMV:MGK) by 9.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,022 shares of the company’s stock after selling 1,698 shares during the period. VANGUARD MEGA CAP 300 GROWTH ETF comprises 1.1% of Fernwood Investment Management LLC’s portfolio, making the stock its 26th biggest holding. Fernwood Investment Management LLC owned approximately 0.06% of VANGUARD MEGA CAP 300 GROWTH ETF worth $1,911,000 as of its most recent filing with the SEC.

Top 10 Safest Stocks For 2019: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on bluebird bio (BLUE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rafi Farber]

    Heres some perspective. Within the past decade, University of Pennsylvania has allied with Novartis A.G. (NYSE: NVS), Baylor College of Medicine with Bluebird Bio Inc. (NASDAQ: BLUE) and Celgene Corp. (NASDAQ:CELG), Memorial Sloan Kettering Cancer Center and the Fred Hutchinson Cancer Research Center with Juno Therapeutics Inc. (NASDAQ: JUNO) (which Celgene just got clearance to acquire), and the National Cancer Institute with Kite Pharma, which was acquired last year byGilead Sciences Inc. (NASDAQ: GILD).

  • [By Keith Speights]

    Bellicum Pharmaceuticals (NASDAQ:BLCM) and bluebird bio (NASDAQ:BLUE) are both clinical-stage biotechs that are developing cutting-edge therapies to treat cancer and other diseases. But the fortunes of these two biotechs have been very different over the last 12 months. Bellicum stock is down 37% during the period, while Bluebird’s share price has soared more than 125%.

  • [By Todd Campbell, Leo Sun, and Daniel Miller]

    For instance, the company recently acquired Juno Therapeutics to get its hands on a pipeline of chimeric antigen receptor T-cell gene therapies (CAR-Ts). CAR-Ts represent one of the biggest recent advances in treating blood cancer, and depending on trial results, the first CAR-T from this collaboration could be filed for approval next year. Similarly, Celgene is partnering with bluebird bio (NASDAQ:BLUE) on bb2121, a CAR-T for multiple myeloma. So far, bb2121 is delivering 90%-plus response rates in heavily pre-treated patients, and if that success continues, it could end up on regulators’ desk for approval next year, too.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 Safest Stocks For 2019: Constellium N.V.(CSTM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Constellium (CSTM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Safest Stocks For 2019: Immersion Corporation(IMMR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Immersion Co. (NASDAQ:IMMR) reached a new 52-week high and low during trading on Friday following a stronger than expected earnings report. The stock traded as low as $13.05 and last traded at $12.34, with a volume of 86458 shares trading hands. The stock had previously closed at $13.21.

  • [By Stephan Byrd]

    ForeScout Technologies (NASDAQ: FSCT) and Immersion (NASDAQ:IMMR) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Shane Hupp]

    Here are some of the news headlines that may have impacted Accern’s analysis:

    Get Immersion alerts:

    Turtle Beach (HEAR) and Immersion (IMMR) Are Aggressive Growth Stocks (finance.yahoo.com) Immersion (IMMR) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com) Is the Options Market Predicting a Spike in Immersion (IMMR) Stock? (zacks.com) Immersion (IMMR) vs. Radisys (RSYS) Head-To-Head Review (americanbankingnews.com) Stock Traders Purchase High Volume of Immersion Put Options (IMMR) (americanbankingnews.com)

    Immersion opened at $13.76 on Friday, according to Marketbeat. Immersion has a 12 month low of $13.32 and a 12 month high of $13.55. The firm has a market cap of $422.28 million, a P/E ratio of -11.56, a P/E/G ratio of 0.53 and a beta of 1.22.

Top 10 Safest Stocks For 2019: Primo Water Corporation(PRMW)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Primo Water Corp. (NASDAQ: PRMW) was started with an Outperform rating at William Blair.BMO Capital Markets maintained its Market Perform rating but the price target was raised to $16 from $15.

  • [By Andy Pai]

    Primo Water Corporation (Nasdaq: PRMW) appears to be the most undervalued stock in the fund. The company has a blended upside of 31.1 percent relative to its current trading price.

  • [By Logan Wallace]

    Primo Water (NASDAQ:PRMW) CFO David J. Mills sold 5,934 shares of the business’s stock in a transaction dated Monday, May 7th. The stock was sold at an average price of $13.50, for a total value of $80,109.00. Following the completion of the transaction, the chief financial officer now owns 79,624 shares in the company, valued at approximately $1,074,924. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Top 10 Safest Stocks For 2019: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In this segment from the Motley Fool Money podcast, host Chris Hill is joined by Jason Moser of Million Dollar Portfolio, David Kretzmann of Hidden Gems Canada, and Aaron Bush of Motley Fool Rule Breakers to discuss the stocks on their radar. Find out why National Beverage (NASDAQ:FIZZ), JPMorgan Chase (NYSE:JPM), and Autodesk (NASDAQ:ADSK) have piqued their interest.

  • [By Jeremy Bowman]

    The company appears to have solved that problem by remaking itself as a sparkling water brand. Not only does that make the product more attractive from a pricing perspective as it’s competing with more expensive bottled waters, but the company is now benefiting from tailwinds in consumer trends as more consumers are drinking bottled and sparkling water in part because of its perceived health benefits compared to soda.Shares ofNational Beverage(NASDAQ:FIZZ) have soared recently on the strength of LaCroix, the flavored sparkling water brand that has developed a following among millennials. In the U.S., sparkling water sales were expected to grow by more than a third last year and from 2011 to 2017 sales of the fizzy water.

Top 10 Safest Stocks For 2019: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Keith Speights]

    What aboutInsys Pharmaceuticals (NASDAQ:INSY)? The biotech’s lead product is an opioid drug, but it also has an approved cannabinoid drug on the market for treatinganorexia in people with AIDS who have lost weight, and chemotherapy-induced nausea and vomiting. Insyshas a couple of experimental pain drugs in its pipeline — but none of them are cannabinoids. The company’s lead cannabinoid candidate targets childhood absence epilepsy, infantile spasms, genetic disorder Prader-Willi syndrome — but not pain.

  • [By Keith Speights]

    Insys Pharmaceuticals (NASDAQ:INSY) and Cara Therapeutics (NASDAQ:CARA) fall into the third category. However, the designations of both Insys and Cara as marijuanastocks warrant an asterisk. Insys’ cannabinoid drug Syndros is based on a synthetic form of THC, the primary psychoactive chemical in marijuana. Cara has a cannabinoid receptor agonist, CR701, in preclinical development.

  • [By Casey Wilson]

    Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

Top 10 Safest Stocks For 2019: CLP Holdings Ltd (2)

Advisors’ Opinion:

  • [By ]

    (1) Cash flow adjusted by working capital and, in the case of Aramco, $21.4 billion owed to the company from the government (2) Production for all companies is the annual average for 2016, the most recent figures available for Aramco

Top 10 Safest Stocks For 2019: EOG Resources, Inc.(EOG)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    The first quarter was an excellent one for the U.S. oil industry. Not only were crude prices at their highest level in years, but shale drillers completed gusher after gusher, enabling most to produce more oil and earnings than expected. EOG Resources (NYSE:EOG) was no different, as it joined several large peers in delivering expectation-beating first-quarter results.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to this latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded up about 0.1% to $77.53, in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 1.1%, at $3.16 in a 52-week range of $2.53 to $6.18. EOG Resources Inc. (NYSE: EOG) traded down about 0.2% to $109.21. The 52-week range is $81.99 to $119.00.

    In addition, the United States Natural Gas ETF (NYSEAMERICAN: UNG) traded up about 0.7%, at $222.17 in a 52-week range of $20.40 to $31.72.

  • [By Matthew DiLallo]

    Today, however, many drillers are setting a high bar for new wells. EOG Resources (NYSE:EOG) has been one of the leaders in disrupting the former way of thinking by establishing a high return hurdle rate for new wells of 30% after-tax at $40 oil. Others followed with similar return-focused approaches, including Encana (NYSE:ECA), which needs locations to achieve a 35% after-tax return at $50 oil to meet its premium hurdle rate.

  • [By Paul Ausick]

    Here’s how share prices of the largest U.S. natural gas producers reacted to this latest report:

    Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded down about 0.1%, at $81.94 in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded up about 5.7%, at $4.16 in a 52-week range of $2.53 to $5.87. EOG Resources Inc. (NYSE: EOG) traded up about 2.6% to $124.62. The 52-week range is $81.99 to $124.69 and the high was posted this morning.

    In addition, the United States Natural Gas ETF (NYSEARCA: UNG) traded down about 0.5%, at $22.84 in a 52-week range of $20.40 to $30.88.

Top 10 Safest Stocks For 2019: EQT Midstream Partners, LP(EQM)

Advisors’ Opinion:

  • [By Shane Hupp]

    SG Americas Securities LLC lowered its stake in shares of EQT Midstream Partners (NYSE:EQM) by 26.1% during the first quarter, HoldingsChannel.com reports. The firm owned 19,964 shares of the pipeline company’s stock after selling 7,067 shares during the period. SG Americas Securities LLC’s holdings in EQT Midstream Partners were worth $1,178,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on EQT Midstream Partners (EQM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    EQT Midstream Partners (NYSE:EQM) had its target price trimmed by Wells Fargo from $79.00 to $69.00 in a research report report published on Monday morning. The firm currently has an outperform rating on the pipeline company’s stock.

Top 10 Medical Stocks To Buy For 2019

The staffing industry – and the IT staffing industry in particular – is poised for tremendous growth in the foreseeable future, and that rising tide bodes very well for Staffing 360 Solutions Inc. (NASDAQ:STAF).

For those who’ve followed the sociopolitical rhetoric it would be easy to conclude what job growth we’ve seen in the past few years has been measly, made even less impressive by the fact most of the new jobs have been less-than-great-career types of jobs. And to be fair, there’s a kernel of truth in what the critics are saying. A closer inspection is merited though, because a closer look clarifies that some industries are seeing tremendous job growth. One of the hottest hot spots? You guessed it … IT jobs.

According to the Bureau of Labor Statistics, software and developer positions will grow by 19% between 2014 and 2024, making it one of the nation’s fastest-growing non-medical career choices. When you broaden the data out to “computer and mathematical occupations”, the ten-year growth projection is 13.1%, which IS the second-highest growth pace among all jobs (second only to healthcare).

Top 10 Medical Stocks To Buy For 2019: ImmuCell Corporation(ICCC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ImmuCell (NASDAQ:ICCC) released its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, Bloomberg Earnings reports. ImmuCell had a negative net margin of 1.61% and a negative return on equity of 0.79%.

Top 10 Medical Stocks To Buy For 2019: Centennial Resource Development, Inc. (CDEV)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)

Top 10 Medical Stocks To Buy For 2019: Provident Financial Services, Inc(PFS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Provident Financial Services alerts:

    Head-To-Head Review: Provident Financial (PROV) versus Provident Financial Services (PFS) (americanbankingnews.com) Head-To-Head Contrast: Territorial Bancorp (TBNK) & Provident Financial Services (PFS) (americanbankingnews.com) Q3 2018 EPS Estimates for Provident Financial Services, Inc. Decreased by Piper Jaffray (PFS) (americanbankingnews.com) Provident Financial Services, Inc. (PFS) Given Average Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of research analysts have issued reports on PFS shares. Sandler O’Neill raised shares of Provident Financial Services from a “hold” rating to a “buy” rating and set a $29.00 price objective on the stock in a research report on Friday, January 26th. ValuEngine raised shares of Provident Financial Services from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Provident Financial Services from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Boenning Scattergood reissued a “hold” rating on shares of Provident Financial Services in a research report on Monday, January 29th. Finally, Piper Jaffray reissued a “hold” rating and set a $28.00 price objective on shares of Provident Financial Services in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Provident Financial Services currently has a consensus rating of “Hold” and an average price target of $28.42.

Top 10 Medical Stocks To Buy For 2019: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    The company appears to have solved that problem by remaking itself as a sparkling water brand. Not only does that make the product more attractive from a pricing perspective as it’s competing with more expensive bottled waters, but the company is now benefiting from tailwinds in consumer trends as more consumers are drinking bottled and sparkling water in part because of its perceived health benefits compared to soda.Shares ofNational Beverage(NASDAQ:FIZZ) have soared recently on the strength of LaCroix, the flavored sparkling water brand that has developed a following among millennials. In the U.S., sparkling water sales were expected to grow by more than a third last year and from 2011 to 2017 sales of the fizzy water.

  • [By Motley Fool Staff]

    In this segment from the Motley Fool Money podcast, host Chris Hill is joined by Jason Moser of Million Dollar Portfolio, David Kretzmann of Hidden Gems Canada, and Aaron Bush of Motley Fool Rule Breakers to discuss the stocks on their radar. Find out why National Beverage (NASDAQ:FIZZ), JPMorgan Chase (NYSE:JPM), and Autodesk (NASDAQ:ADSK) have piqued their interest.

Top 10 Medical Stocks To Buy For 2019: Houston Wire & Cable Company(HWCC)

Advisors’ Opinion:

  • [By Max Byerly]

    Houston Wire & Cable (NASDAQ:HWCC) hit a new 52-week high and low during mid-day trading on Wednesday after an insider bought additional shares in the company. The stock traded as low as $8.40 and last traded at $8.35, with a volume of 604 shares traded. The stock had previously closed at $7.90.

Top 10 Medical Stocks To Buy For 2019: Hanwha Q CELLS Co., Ltd. (HQCL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Agilent Technologies, Inc. (NYSE: A) to post quarterly earnings at $0.64 per share on revenue of $1.21 billion after the closing bell. Agilent shares rose 0.86 percent to close at $69.45 on Friday.
    Analysts expect Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) to report quarterly earnings at $0.14 per share on revenue of $438.40 million before the opening bell. Hanwha Q CELLS shares fell 0.29 percent to close at $6.92 on Friday.
    NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. NiSource shares rose 0.08 percent to close at $24.93 on Friday.
    Analysts are expecting Vipshop Holdings Limited (NYSE: VIPS) to have earned $0.18 per share on revenue of $3.10 billion in the latest quarter. Vipshop will release earnings after the markets close. Vipshop shares rose 0.20 percent to $15.14 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is estimated to report quarterly earnings at $0.14 per share on revenue of $438.40 million.
    Remark Holdings, Inc. (NASDAQ: MARK) is projected to report quarterly loss at $0.35 per share on revenue of $19.45 million.
    Athenex, Inc. (NYSE: ATNX) is expected to report quarterly loss at $0.07 per share on revenue of $35.14 million.
    Mazor Robotics Ltd. (NASDAQ: MZOR) is estimated to report quarterly loss at $0.08 per share on revenue of $15.14 million.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) is projected to report a quarterly loss at $0.14 per share.
    SuperCom Ltd. (NASDAQ: SPCB) is expected to report quarterly earnings at $0.08 per share on revenue of $9.50 million.
    Lonestar Resources US Inc. (NASDAQ: LONE) is projected to report quarterly loss at $0.04 per share on revenue of $30.68 million.
    Nine Energy Service, Inc. (NASDAQ: NINE) is estimated to report quarterly earnings at $0.1 per share on revenue of $165.76 million.
    VEON Ltd. (NASDAQ: VEON) is projected to report quarterly earnings at $0.05 per share on revenue of $212.00 million.

     

Top 10 Medical Stocks To Buy For 2019: Express-1 Expedited Solutions Inc.(XPO)

Advisors’ Opinion:

  • [By Rich Duprey, Nicholas Rossolillo, and Maxx Chatsko]

    Yet finding the best stocks to buy and hold isn’t easy. So to help get you started, we asked three Foolish investors to pick a growth stock that they believe investors would be wise to buy now and hold for the long term. Read on to learn why they like SunPower (NASDAQ:SPWR), salesforce.com (NYSE:CRM), and XPO Logistics (NYSE:XPO).

  • [By Jeremy Bowman]

    ARecode article in December made waves when it asserted that Home Depot was considering acquiringXPO Logistics(NYSE:XPO), the U.S. leader in last-mile delivery of heavy goods like furniture and appliances. Home Depot already has a close relationship with XPO, naming it its Mid-Size Truckload Carrier of the year in 2015, and was reportedly interested in acquiring it in part to keep it out of the hands of Amazon, which has been ramping up efforts to sell products like furniture, and is also an XPO customer.

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Thursday’s trending stocks from the floor of the New York Stock Exchange including Macy’s (M) , Amazon (AMZN) , Etsy (ETSY) , XPO Logistics (XPO) and Groupon (GRPN) . 

  • [By Logan Wallace]

    XPO Logistics (NYSE:XPO)‘s stock had its “buy” rating reissued by research analysts at Bank of America in a research note issued on Friday. They presently have a $105.00 target price on the transportation company’s stock. Bank of America’s price objective would indicate a potential upside of 4.86% from the stock’s previous close.

Top 10 Medical Stocks To Buy For 2019: US Foods Holding Corp. (USFD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Discovery, Inc. (NASDAQ: DISCA) to report quarterly earnings at $0.44 per share on revenue of $1.99 billion before the opening bell. Discovery shares rose 0.47 percent to $23.50 in pre-market trading.
    Analysts expect Marriott International, Inc. (NASDAQ: MAR) to post quarterly earnings at $1.22 per share on revenue of $5.72 billion after the closing bell. Marriott shares gained 0.08 percent to $136.75 in pre-market trading.
    Veeco Instruments Inc. (NASDAQ: VECO) reported stronger-than-expected earnings for its first quarter. Veeco Instruments shares surged 14.04 percent to $19.50 in the after-hours trading session.
    Before the markets open, DISH Network Corporation (NASDAQ: DISH) is projected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion. DISH shares gained 1.53 percent to close at $33.90 on Monday.
    Analysts are expecting US Foods Holding Corp. (NYSE: USFD) to have earned $0.32 per share on revenue of $5.98 billion in the latest quarter. US Foods will release earnings before the markets open. US Foods shares rose 0.57 percent to close at $33.72 on Monday.
    Snap Inc (NYSE: SNAP) disclosed that its CFO Andrew Vollero will leave the company and Amazon.com's VP Of Finance Tim Sloan will assume the role. Snap shares gained 1.3 percent to $10.88 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o

Top 10 Medical Stocks To Buy For 2019: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By ]

    Teva Pharmaceuticals (TEVA) : “No, Teva isn’t good enough. We need growth and yield, and they don’t have it.”

    Chicago Mercantile Exchange (CME) : “That’s an ideal stock for this market. I like the choice.”

  • [By Chris Lange]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its most recent quarterly report before the markets opened on Thursday. The pharma giant said that it had $0.94 in earnings per share (EPS) on $5.1 billion in revenue. Consensus estimates had called for $0.66 in EPS on $4.8 billion in revenue. The same period of last year had $1.06 in EPS on $5.63 billion in revenue.

  • [By Dan Caplinger]

    The stock market posted small advances on Monday, with most major benchmarks picking up between 0.4% and 0.8%. Much of the attention on Wall Street centered on other financial markets, which included favorable price action in oil, a surge in the value of the U.S. dollar against many foreign currencies, and relatively weak performance from gold. Yet there was still plenty of good news that sent individual companies’ shares higher. Teva Pharmaceutical Industries (NYSE:TEVA), Gramercy Property Trust (NYSE:GPT), and Medtronic (NYSE:MDT) were among the best performers on the day. Here’s why they did so well.

Top 10 Medical Stocks To Buy For 2019: ClearBridge Energy MLP Total Return Fund Inc.(CTR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

  • [By Joseph Griffin]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

  • [By Logan Wallace]

    Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.

top five stocks to buy

U.S. equities melted higher on Thursday, pushing large-caps to new record highs, thanks to strength in crude oil (providing much needed relief to the energy sector after Wednesday’s decline) driven by a larger-than-expected inventory drawdown. In fact, it was the largest draw since 2016 even as production hits a 21-month high, suggesting strong-end demand.

Will it be enough to offset surging U.S. shale output? Likely not. Especially since OPEC’s compliance with its supply freeze agreement is falling (the headlines that pushed the energy complex lower on Wednesday). Late-session selling in crude supports this thesis.

In the end, the Dow Jones Industrial Average gained 0.7% (new high), the S&P 500 gained 0.8% (new high), the Nasdaq Composite gained 0.8% (new high) and the Russell 2000 gained 1.9%. Treasury bonds weakened, the dollar climbed, gold lost 0.4% and oil gained 0.1% more sizable gains earlier in the session faded away. In fact, the United States Oil Fund LP (ETF) (NYSEARCA:USO) actually closed in the red, down 0.5%, after trading up as much as 2%.

top five stocks to buy: Piedmont Natural Gas Company Inc.(PNY)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    Duke also recently has expanded on its natural gas efforts, and will add numerous more natural gas customers when its buy-out of Piedmont Natural Gas Company, Inc. (PNY) goes through.

top five stocks to buy: Gol Linhas Aereas Inteligentes S.A.(GOL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Gol Linhas Aereas Inteligentes SA (ADR) (NYSE: GOL) is expected to post a quarterly loss at $0.73 per share on revenue of $705.31 million.

    Caretrust REIT Inc (NASDAQ: CTRE) is estimated to post its quarterly earnings at $0.26 per share on revenue of $22.21 million.

  • [By Lisa Levin]

    Regional Airlines: The industry dropped 1.9 percent by 11:00 am. The worst performer in this industry was Gol Linhas Aereas Inteligentes SA (ADR) (NYSE: GOL), which declined 5.8 percent.

  • [By Dan Caplinger]

    Yet some stocks didn’t participate in the rally, instead contending with negative news of their own. Zoe’s Kitchen (NYSE:ZOES), GOL Lineas Aereas Inteligentes (NYSE:GOL), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

top five stocks to buy: Sonic Corp.(SONC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of newcomers Shake Shack and California based IPO Habit Restaurants both underperforming or below their IPO close prices whilemore established small capburger stocks Red Robin Gourmet Burgers, Inc (NASDAQ: RRGB) and Sonic Corporation (NASDAQ: SONC) were big outperformers up until more recently:

  • [By Peter Graham]

    A long term performance chart shows shares of small caps Habit Restaurants and Shake Shack Inc (NYSE: SHAK) below their IPO prices while more established burger stocks Red Robin Gourmet Burgers, Inc (NASDAQ: RRGB) and Sonic Corporation (NASDAQ: SONC)have seen their performance drift downward last year or the year before:

  • [By Peter Graham]

    After the market closed yesterday, small cap burger stock Sonic Corporation (NASDAQ: SONC) reported fiscalQ2 2017 earnings with shares falling moderately in after hours trading as the top line missed and the bottom line met expectations. However, it appears analysts are zeroing in on the system same-store sales comps down 7.4% versus expectations for a fall of 4.3%. The decline was comprised of a7.3% same-store sales decline at franchise drive-ins and a decline of 8.9% at company drive-ins.

top five stocks to buy: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    Tailored Brands (NYSE:TLRD) and National Beverage (NASDAQ:FIZZ) were two of the biggest individual stock movers on Thursday.

    Winners and losers

    Shares of formal clothing specialist Tailored Brands dove 32% after the companyposted surprisingly weak fiscal fourth-quarter earnings results. Sales fell 3.9% to $793 million, while consensus estimates were targeting a more modest decline to $805 million.

  • [By Dan Caplinger]

    Yet some solid individual stock gains also helped lift investors’ moods, and Sears Holdings (NASDAQ:SHLD), National Beverage (NASDAQ:FIZZ), and JetBlue Airways (NASDAQ:JBLU) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 5 Blue Chip Stocks To Own Right Now

On Wednesday, stocks recovered following the worst day overall since October. The gains were led by the technology sector, which in many cases reversed following their worst day of the year on Tuesday.

However, despite the tech rebound, the blue chips lagged pulling the Dow Jones Industrial Average down less than 0.1%. Nike Inc (NYSE:NKE), a Dow component, fell 7.1%, pulled lower by a lackluster outlook for sales growth.

The technology sector of the S&P 500 rose 0.8%, its biggest gain in three weeks. The Nasdaq, which is tech heavy, rose 0.5%, and the 500 jumped chiefly on gains by technology giants Microsoft Corporation (NASDAQ:MSFT), up 1.3%, Apple Inc. (NASDAQ:AAPL), up 1.1%, and Facebook Inc (NASDAQ:FB), up 1.1%. The PHLX Semiconductor Index (NASDAQ:SOXX) did its part by gaining 1.1%.

Crude oil (WTI) fell 0.4% as data showed that stockpiles of crude hit a new record high. Spot WTI closed at $48.04 per barrel for a fall of 11% so far in March.

At the close, the Dow Jones Industrial Average fell 7 points at 20,661, the S&P 500 rose 4 to 2,348, the Nasdaq gained 28 points to close at 5,822, and the Russell 2000 fell a point to 1,346. The NYSE ‘s primary exchange traded 899 million shares with total volume of 3.5 billion shares, and the Nasdaq crossed 1.8 billion shares. On the Big Board, advancers exceeded decliners by 1.1-to-1, and on the Nasdaq, decliners led by 1.3-to-1. Blocks on the NYSE fell to 6,935 from 7,804 on Tuesday.

Top 5 Blue Chip Stocks To Own Right Now: Advance Auto Parts Inc(AAP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Advance Auto Parts (AAP) surged to the top of the S&P 500 today after releasing better-than-expected third-quarter earnings.

    Getty Images

    Shares of Advance Auto Parts gained 15% to $164.33, while the S&P 500 rose 0.8% to 2,180.39.

    Credit Suisse analyst Seth Sigman and team explain why shares of Advance Auto Parts are soaring:

    Advance Auto Parts’ Q3 and strategic update was one of the better scenarios for this stock with better than expected comps, positive commentary on Q4, a roughly in line 2017 outlook, and a new sense of direction on how this new management team will narrow the margin gap with peers. Management guided to a 500 bps long-term margin improvement, which wasnt a surprise to investors, and other specifics were still limited. However, timed with Q3/4′s improvement, this should help instill some early confidence in this team. We are adjusting our 2016 and 2017 EPS modestly, to $7.30 (from $7.23) and to $7.65 (from $7.60) respectively.

    Advance Auto Parts market capitalization rose to $12.1 billion today from $10.7 billion yesterday.

  • [By WWW.THESTREET.COM]

    So here’s a disruptive move. Consider buying auto parts retailer Advance Auto Parts (AAP) , the weakest of the big three in the sector, which has 5,000-plus locations in the U.S. The other two players are O’Reilly Automotive, Inc. (ORLY) , the fastest-growing of the three, and AutoZone, Inc. (AZO) .

  • [By Spencer Israel]

     

    Riot Blockchain Inc (NASDAQ: RIOT) – The Jan. 2015 high of $15.72 is the only resistance it has.
    General Electric Company (NYSE: GE) -The low of the move is a double bottom at $17.46 and  $17.50. That’s support.
    Overstock.com Inc (NASDAQ: OSTK) – The February 2005 high was $58.24, which is the only relevant resistance up here. On weakness, keep an eye on the all-time closing high of $56.65 made on Monday.
    Advance Auto Parts, Inc. (NYSE: AAP) – Is trying to fill the gap from earnings between $82.82 and $94.75.
    Tesla Motors Inc (NASDAQ: TSLA) – It needs to clear Friday’s close of $315.05 and Monday’s high of $315.50 to find support.
    Urban Outfitters, Inc. (NASDAQ: URBN) – There was a double close at $27.90 from Friday and $28.27 from Monday, so that’s resistance.
    DSW Inc. (NYSE: DSW) -The premarket low was $18.40. There are also four daily lows at the $18.40 area from early November, and the low of the move is $17.89.
    Signet Jewelers Ltd. (NYSE: SIG) – the premarket low was $61.50, which was the low of the move. There’s daily lows at the $61 area from mid-August, and another pair of lows at $60. Below that, there’s a gap area down to $52.95.
    Lowe’s Companies, Inc. (NYSE: LOW)- The Friday low was $79.17, and a pair of lows from Wednesday and Thursday at $78.27 and $78.23.
    Campbell Soup Company (NYSE: CPB) – The buy zone is between $45-$46. The low of the move was $44.99, flanked by the $45.14 low the following day.
    Dollar Tree, Inc. (NASDAQ: DLTR) – $99.93 and a big psychological number at $100.
    Burlington Stores Inc (NYSE: BURL) – The Monday low was $104.55. The all-time high and all-time closing high are $106.55 and $106.89, respectively. 
    Exxon Mobil Corporation (NYSE: XOM) – Big triple bottom at $80.

    Watch the full show below!

  • [By ]

    3. Advance Auto Parts (NYSE: AAP)
    A leader in the consumer auto parts space, Advance boasts over 5,200 stores, 100 Worldpac branches, and serves more than 1,300 independently owned CARQUEST branded shops.

  • [By Lee Samaha]

    The key issue to focus on is automotive group comparable sales, which can be seen in the chart below. I’ve also included the most directly applicable sales numbers for its peers,O’Reilly Automotive Inc (NASDAQ:ORLY), AutoZone, Inc (NYSE:AZO) and Advance Auto Parts, Inc. (NYSE:AAP). The disappointing sales performance of Advance Auto Parts is largely due to the effects of integrating a troublesome acquisition.

Top 5 Blue Chip Stocks To Own Right Now: Virtus Investment Partners Inc.(VRTS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Virtus Investment Partners Inc (NASDAQ: VRTS) got a boost, shooting up 19 percent to $111.05 following Q3 results. Virtus Investment posted Q3 earnings of $1.64 per share on revenue of $82.3 million.

Top 5 Blue Chip Stocks To Own Right Now: FEI Company(FEIC)

Advisors’ Opinion:

  • [By Lisa Levin]

    FEI Company (NASDAQ: FEIC) shares were also up, gaining 14 percent to $108.00 as the company agreed to be acquired by Thermo Fisher Scientific Inc. (NYSE: TMO) for $4.2 billion.

Top 5 Blue Chip Stocks To Own Right Now: Catalyst Pharmaceuticals, Inc.(CPRX)

Advisors’ Opinion:

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

  • [By Lisa Levin]

    Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) got a boost, shooting up 32 percent to $1.54 after the company reported positive data from investigator-sponsored trial of Firdapse.

Top 5 Blue Chip Stocks To Own Right Now: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Yet some solid individual stock gains also helped lift investors’ moods, and Sears Holdings (NASDAQ:SHLD), National Beverage (NASDAQ:FIZZ), and JetBlue Airways (NASDAQ:JBLU) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Demitrios Kalogeropoulos]

    Tailored Brands (NYSE:TLRD) and National Beverage (NASDAQ:FIZZ) were two of the biggest individual stock movers on Thursday.

    Winners and losers

    Shares of formal clothing specialist Tailored Brands dove 32% after the companyposted surprisingly weak fiscal fourth-quarter earnings results. Sales fell 3.9% to $793 million, while consensus estimates were targeting a more modest decline to $805 million.

stock market today chart

It’s busy season for immigration lawyers. On April 3, people can start submitting H-1B visa petitions for the new fiscal year.

The popular visa, beloved by the tech industry, is a pathway for skilled foreigners to work in the U.S.

It’s in high demand: Last year, the cap of 85,000 H-1B visas was reached less than a week after the application period opened up. During that time, 236,000 petitions were submitted.

When demand exceeds supply, the visas are awarded through a lottery system.

And this year, there are additional stress factors: The political environment is decidedly less welcoming to foreigners and one of the favored processing options has been put on hold.

For an additional $1,225 fee, premium processing guarantees that an H-1B petition is reviewed within 15 days (if it’s selected in the lottery). According to USCIS, premium processing filings accounted for 59% of the total H-1B filings in 2016. But in March, USCIS announced it was temporarily freezing that option on April 3.

stock market today chart: Francesca's Holdings Corporation(FRAN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, cyclical consumer goods & services shares fell 0.03 percent. Meanwhile, top losers in the sector included Francesca's Holdings Corp (NASDAQ: FRAN), down 5 percent, and Hibbett Sports, Inc. (NASDAQ: HIBB) down 5 percent.

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

  • [By Ben Levisohn]

    Francesca’s Holdings (FRAN) has jumped 5.4% to $11.00 after beating earnings forecasts.

    Restoration Hardware (RH) has tumbled 20% to $28.92 after slashing its full-year guidance. Restoration Hardware was also cut to Market Perform from Outperform at Telsey Advisory Group.

stock market today chart: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Matthew Briar]

    Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.

    The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.

    Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.

    More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe

  • [By Jim Robertson]

    Last week, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP)announced a deal with Hempco Food and Fiber (OTCMKTS: HMPPF; TSXV: HEMP) that will take hemp foods to the next level. First of all, hemp is a variety of the Cannabis sativa plant species that is grown for the industrial uses of its derived products as the plant material can be refined into justabout anything,including paper, textiles, clothing, biodegradable plastics, paint, insulation, biofuel, food and animal feed:

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Bryan Murphy]

    At first glance, it looks like it could be trouble for Lexaria Bioscience Corp (OTCMKTS:LXRP). That is, on Wednesday, the nation’s Drug Enforcement Agency brought clarity to a rule that had been up in the air since 2011. That is, in short, the DEA’s position on all cannabis extracts, including CBD oil, is that they are all federally illegal Schedule I substances.

    From a legal and logical standpoint based just on the DEA’s language published in the Federal Register yesterday, that puts Lexaria Bioscience in jeopardy. Lexaria has developed a way to improve the body’s absorption of hemp oil — which is deliberately high in cannabidiol/CBD — which was perfectly legal and legitimate since THC percentage in hemp (0.3%or less) are technically legal. Now the federal government’s drug-enforcement arm says that’s not the case. The newly-clarified law defines the illegal substance as “extracts that have been derived from any plant of the genus Cannabis and which contain cannabinols and cannabidiols.” Hemp, even though it’s not marijuana, is of the Cannabis genus.

    Bad news for LXRP owners? Not quite, for a handful of reasons.

    The decision (which bypassed legislature and overstepped the DEA’s authority, by the way – more on that in a second) is evidence of a long-standing problem the government agency has had in dealing with hemp and cannabis. In simplest terms, the DEA has operated and acted as if it has no real understanding of the difference between hemp and marijuana. They are of the same genus, but not of the same species. Moreover, while the former predominantly contains cannabidiol, the latter is sought out for its high tetrahydrocannabinol (or THC) for the purpose of creating a “high.”

    Problem (for the DEA): The U.S. judicial system has already ruled that the DEA doesn’t have the authority to make such rules.

    Attorney Robert Hoban explained yesterday evening at industry website newcannabisventures.com:

stock market today chart: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Oaktree Capital Group (OAK) is known for its contrarian approach with many of its products concentrating on distressed assets and turnaround situations.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

stock market today chart: Rent-A-Center Inc.(RCII)

Advisors’ Opinion:

  • [By Lisa Levin]

    Rent-A-Center Inc (NASDAQ: RCII) was down, falling around 26 percent to $9.88. Rent-A-Center reported upbeat quarterly earnings, but the company’s sales missed analysts’ estimates.

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basically breaking even with Best Buy Co Inc (NYSE: BBY) all over the place (albeit it took off again last year) while small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both underperformed for over three years now:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc performing better with Best Buy Co Inc (NYSE: BBY) being the big winner whilesmall caps hhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII) haveunderperformed, butare showing signs of improvement:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basicallyabove break even with Best Buy Co Inc (NYSE: BBY)taking off againwhile small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both been sliding in recent years:

stock market today chart: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    Tailored Brands (NYSE:TLRD) and National Beverage (NASDAQ:FIZZ) were two of the biggest individual stock movers on Thursday.

    Winners and losers

    Shares of formal clothing specialist Tailored Brands dove 32% after the companyposted surprisingly weak fiscal fourth-quarter earnings results. Sales fell 3.9% to $793 million, while consensus estimates were targeting a more modest decline to $805 million.

  • [By Dan Caplinger]

    Yet some solid individual stock gains also helped lift investors’ moods, and Sears Holdings (NASDAQ:SHLD), National Beverage (NASDAQ:FIZZ), and JetBlue Airways (NASDAQ:JBLU) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.